These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 1025340)

  • 1. Recombinant influenza-virus vaccines: II. Some properties of high-yielding recombinant influenza viruses and their vaccines.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):27-41. PubMed ID: 1025340
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on genetic recombinants of influenza virus: fundamental studies on recombinant influenza-virus vaccines.
    Higashihara M
    Kitasato Arch Exp Med; 1975 Dec; 48(4):183-8. PubMed ID: 1234926
    [No Abstract]   [Full Text] [Related]  

  • 3. Recombinant influenza-virus vaccines. IV. Segregation of antigenic and some biological properties of Influenza virus neuraminidase by recombination.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):81-91. PubMed ID: 1029759
    [No Abstract]   [Full Text] [Related]  

  • 4. Recombinant influenza-virus vaccines. III. Isolation and preliminary characterization of so-called antigenic recombinant influenza viruses.
    Higashihara M; Igarashi Y; Saito Y
    Kitasato Arch Exp Med; 1976 Sep; 49(3):67-79. PubMed ID: 1029758
    [No Abstract]   [Full Text] [Related]  

  • 5. Recombinant influenza-virus vaccines: I. Rapid derivation and preliminary characterization of high-yielding recombinants of influenza virus.
    Higashihara M; Igarashi Y; Nakagawa S; Saito Y
    Kitasato Arch Exp Med; 1976 Jun; 49(1-2):1-26. PubMed ID: 1025339
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental basis of enhancing the immunogenicity of influenza B virus by genetic recombination.
    Medvedeva TE; Gordon MA; Aleksandrova GI; Smorodintsev AA
    Acta Virol; 1980 Dec; 24(6):385-90. PubMed ID: 6111198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influenza viruses and influenza vaccines (author's transl)].
    Paccaud MF
    Ther Umsch; 1974 Jun; 31(6):372-80. PubMed ID: 4467349
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of the antibody response to inactivated A2-Hong Kong vaccines by previous heterotypic influenza virus infection.
    Potter CW; Jennings R; Marine WM; McLaren C
    Microbios; 1973; 8(30):101-10. PubMed ID: 4801251
    [No Abstract]   [Full Text] [Related]  

  • 9. Future influenza vaccines and the use of genetic recombinants.
    Kilbourne ED
    Bull World Health Organ; 1969; 41(3):643-5. PubMed ID: 5309489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitivity of gamma-m antibody response in mice injected with killed influenza virus.
    Berlin BS
    Radiat Res; 1965 Dec; 26(4):554-66. PubMed ID: 5849708
    [No Abstract]   [Full Text] [Related]  

  • 11. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain.
    de Wit E; Munster VJ; Spronken MI; Bestebroer TM; Baas C; Beyer WE; Rimmelzwaan GF; Osterhaus AD; Fouchier RA
    J Virol; 2005 Oct; 79(19):12401-7. PubMed ID: 16160167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.
    Kreijtz JH; Suezer Y; van Amerongen G; de Mutsert G; Schnierle BS; Wood JM; Kuiken T; Fouchier RA; Lower J; Osterhaus AD; Sutter G; Rimmelzwaan GF
    J Infect Dis; 2007 Jun; 195(11):1598-606. PubMed ID: 17471429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant vaccinia virus with influenza hemagglutinin protects old mice from influenza infection.
    Ben-Yehuda A; Ehleiter D; Hu AR; Weksler ME
    Trans Assoc Am Physicians; 1992; 105():177-81. PubMed ID: 1308994
    [No Abstract]   [Full Text] [Related]  

  • 14. The humoral immune response and protective efficacy of vaccination with inactivated split and whole influenza virus vaccines in BALB/c mice.
    Cox RJ; Hovden AO; Brokstad KA; Szyszko E; Madhun AS; Haaheim LR
    Vaccine; 2006 Nov; 24(44-46):6585-7. PubMed ID: 16839650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An 'in vitro' marker of attenuation for live influenza virus vaccine candidates.
    Mostow SR; Flatauer S; Martinko J
    Dev Biol Stand; 1975; 28():354-62. PubMed ID: 1126579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of influenza B virus recombinant strains.
    Podchernyaeva RYa ; Shchipanova MV; Elkin VS; Melnichenko EI
    Acta Virol; 1987 Nov; 31(6):475-80. PubMed ID: 2894141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of mice with recombinant influenza virus neuraminidase.
    Kilbourne ED; Pokorny BA; Johansson B; Brett I; Milev Y; Matthews JT
    J Infect Dis; 2004 Feb; 189(3):459-61. PubMed ID: 14745703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Now and future influenza vaccines.
    Ruben FL
    Infect Dis Clin North Am; 1990 Mar; 4(1):1-10. PubMed ID: 2407775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antigenic subunits of influenza viruses. I. The homologous antibody response.
    Fazekas de Saint Groth ; Webster RG; Davenport FM
    J Immunol; 1969 Nov; 103(5):1099-106. PubMed ID: 5350969
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.